منابع مشابه
Session IV: Prostate Prostate cancer and imaging
Prostate cancer’s incidence, prevalence, etiology, and risk factors, and the influence of clinical trials on imaging technology development are discussed. One in seven Western men older than 70 will develop prostate cancer. The advent of prostate-specific antigen (PSA) screening means most men will now be diagnosed with early disease (85% not palpable on digital rectal exam (DRE), fewer grade 8...
متن کاملPodium for the opposition?
This is quite a paradoxical era. Scientific research is in its most productive phase and it continues to produce many beneficial technologies for mankind. For example, we rapidly progress towards a better understanding of many diseases and come up with multiple new approaches to cure them. At the same time, however, the voices against science and technology have never been more shrill. But unsu...
متن کاملFirst Day Session 1 : Opening Session
Reuse of experience and solutions for recurring development problems is of the utmost importance for a pragmatic software engineering discipline. The earlier in the development process reuse is achieved, the larger its positive impact on the project. This paper reports on reuse approaches that are applicable during the requirements analysis phase.
متن کاملSession Wednesday January 21 st , 2015 Session 1 : 1 : 00 - 1 : 50 pm Session 2 : 1 : 50 - 2 : 45 pm
متن کامل
Abstracts—session 1
S — SESSION 1 Sunday 10 October 2004, 15.00–16.00 PET, CT and tumor markers in the evaluation of postchemotherapy residuals in metastatic germ-cell tumors A C Pfannenberg, K Oechsle‡, C Kollmannsberger‡, B M Dohmen†, C Bokemeyer‡, R Bares† and C D Claussen Departments of Diagnostic Radiology, †Nuclear Medicine and ‡Oncology, University of Tuebingen, Hoppe-Seyler-Strasse 3, 72076 Tuebingen, Germ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Canadian Urological Association Journal
سال: 2013
ISSN: 1920-1214,1911-6470
DOI: 10.5489/cuaj.1282